{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:16:42Z","timestamp":1772810202087,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Cancer Center","award":["29-A-14"],"award-info":[{"award-number":["29-A-14"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s12185-020-02890-1","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T15:03:46Z","timestamp":1590764626000},"page":"193-199","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["T-cell posttransplant lymphoproliferative disorders after allogeneic hematopoietic cell transplantation"],"prefix":"10.1007","volume":"112","author":[{"given":"Masatomo","family":"Kuno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5681-6357","authenticated-orcid":false,"given":"Ayumu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko Miyagi","family":"Maeshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saiko","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"key":"2890_CR1","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1182\/blood.V72.2.520.520","volume":"72","author":"MM Zutter","year":"1988","unstructured":"Zutter MM, Martin PJ, Sale GE, et al. Epstein\u2013Barr virus lymphoproliferation after bone marrow transplantation. Blood. 1988;72:520\u20139.","journal-title":"Blood"},{"key":"2890_CR2","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1182\/blood-2008-09-178046","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Gilbert ES, Rizzo JD, Socie G, Banks PM, Sobocinski KA, et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood. 2009;113:4992\u20135001.","journal-title":"Blood"},{"key":"2890_CR3","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/cid\/cit391","volume":"57","author":"J Styczynski","year":"2013","unstructured":"Styczynski J, Gil L, Tridello G, Ljungman P, Donnelly JP, van der Velden W, et al. Response to rituximab-based therapy and risk factor analysis in Epstein Barr virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Clin Infect Dis. 2013;57:794\u2013802.","journal-title":"Clin Infect Dis"},{"key":"2890_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMra1702693","volume":"378","author":"D Dierickx","year":"2018","unstructured":"Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. N Engl J Med. 2018;378:549\u201362.","journal-title":"N Engl J Med"},{"key":"2890_CR5","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.bbmt.2019.02.016","volume":"25","author":"A Fujimoto","year":"2019","unstructured":"Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Uchida N, Maeda T, et al. Risk factors and predictive scoring system for post-transplantation lymphoproliferative disorder after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2019;25:1441\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2890_CR6","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.3109\/10428194.2013.775436","volume":"54","author":"A Herreman","year":"2013","unstructured":"Herreman A, Dierickx D, Morscio J, Camps J, Bittoun E, Verhoef G, et al. Clinicopathological characteristics of posttransplant lymphoproliferative disorders of T-cell origin: single-center series of nine cases and meta-analysis of 147 reported cases. Leuk Lymphoma. 2013;54:2190\u20139.","journal-title":"Leuk Lymphoma"},{"key":"2890_CR7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/TP.0b013e3182762e07","volume":"95","author":"C Tiede","year":"2013","unstructured":"Tiede C, Maecker-Kolhoff B, Klein C, Kreipe H, Hussein K. Risk factors and prognosis in T-cell posttransplantation lymphoproliferative diseases: reevaluation of 163 cases. Transplantation. 2013;95:479\u201388.","journal-title":"Transplantation"},{"key":"2890_CR8","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2017.","edition":"4"},{"key":"2890_CR9","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/ajcp\/94.6.714","volume":"94","author":"MM Zutter","year":"1990","unstructured":"Zutter MM, Durnam DM, Hackman RC, Loughran TP Jr, Kidd PG, Ashley RL, et al. Secondary T-cell lymphoproliferation after marrow transplantation. Am J Clin Pathol. 1990;94:714\u201321.","journal-title":"Am J Clin Pathol"},{"key":"2890_CR10","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/sj.bmt.1702610","volume":"26","author":"LC Wang","year":"2000","unstructured":"Wang LC, Lu MY, Yu J, Jou ST, Chiang IP, Lin KH, et al. T cell lymphoproliferative disorder following bone marrow transplantation for severe aplastic anemia. Bone Marrow Transplant. 2000;26:893\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"2890_CR11","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1309\/VA755A03PVRV9XDT","volume":"120","author":"WY Au","year":"2003","unstructured":"Au WY, Lam CC, Lie AK, Pang A, Kwong YL. T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation. Am J Clin Pathol. 2003;120:626\u201330.","journal-title":"Am J Clin Pathol"},{"key":"2890_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1309\/GLH5NVCFB9BKMV9G","volume":"123","author":"H Chang","year":"2005","unstructured":"Chang H, Kamel-Reid S, Hussain N, Lipton J, Messner HA. T-cell large granular lymphocytic leukemia of donor origin occurring after allogeneic bone marrow transplantation for B-cell lymphoproliferative disorders. Am J Clin Pathol. 2005;123:196\u20139.","journal-title":"Am J Clin Pathol"},{"key":"2890_CR13","doi-asserted-by":"publisher","first-page":"e778","DOI":"10.1111\/j.1365-2230.2009.03509.x","volume":"34","author":"A Santos-Briz","year":"2009","unstructured":"Santos-Briz A, Romo A, Antunez P, Roman C, Alcoceba M, Garcia JL, et al. Primary cutaneous T-cell lymphoproliferative disorder of donor origin after allogeneic haematopoietic stem-cell transplantation. Clin Exp Dermatol. 2009;34:e778\u2013e781.","journal-title":"Clin Exp Dermatol"},{"key":"2890_CR14","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/bmt.2009.347","volume":"45","author":"A Nishida","year":"2010","unstructured":"Nishida A, Yamamoto H, Ohta Y, Karasawa M, Kato D, Uchida N, et al. T-cell post-transplant lymphoproliferative disorder in a patient with chronic idiopathic myelofibrosis following allogeneic PBSC transplantation. Bone Marrow Transplant. 2010;45:1372\u20134.","journal-title":"Bone Marrow Transplant"},{"key":"2890_CR15","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.2169\/internalmedicine.53.2384","volume":"53","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Takizawa J, Miyakoshi S, Kozakai T, Fuse K, Shibasaki Y, et al. Manifestations of fulminant CD8 T-cell post-transplant lymphoproliferative disorder following the administration of rituximab for lymphadenopathy with a high level of Epstein\u2013Barr Virus (EBV) replication after allogeneic hematopoietic stem cell transplantation. Intern Med. 2014;53:2115\u20139.","journal-title":"Intern Med"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02890-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-020-02890-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02890-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T23:17:20Z","timestamp":1622243840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-020-02890-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["2890"],"URL":"https:\/\/doi.org\/10.1007\/s12185-020-02890-1","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]},"assertion":[{"value":"23 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}